|
RAI14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.118300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.654380E-02 |
| Normal-vs-Stage2 |
8.791500E-02 |
| Normal-vs-Stage3 |
5.162300E-03 |
| Normal-vs-Stage4 |
1.897690E-02 |
| Stage1-vs-Stage2 |
1.386330E-04 |
| Stage1-vs-Stage3 |
1.317820E-01 |
| Stage1-vs-Stage4 |
1.747610E-01 |
| Stage2-vs-Stage3 |
2.420600E-04 |
| Stage2-vs-Stage4 |
1.744290E-03 |
| Stage3-vs-Stage4 |
9.123000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.401360E-03 |
| Normal-vs-AfricanAmerican |
1.417740E-02 |
| Normal-vs-Asian |
2.320100E-02 |
| Caucasian-vs-AfricanAmerican |
2.899000E-01 |
| Caucasian-vs-Asian |
5.371400E-01 |
| AfricanAmerican-vs-Asian |
5.927800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.810000E-02 |
| Normal-vs-Female |
2.662300E-03 |
| Male-vs-Female |
6.289400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.182800E-03 |
| Normal-vs-Age(41-60Yrs) |
3.830200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.784760E-01 |
| Normal-vs-Age(81-100Yrs) |
2.445400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.072400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.986800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.986400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.616800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.676200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.469200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.788980E-01 |
| Classical-VS-Follicular |
1.62914126633495E-12 |
| Classical-VS-Other |
4.229000E-01 |
| Classical-VS-Normal |
2.25249999999955E-05 |
| Tall-VS-Follicular |
1.063900E-03 |
| Tall-VS-Other |
2.507600E-01 |
| Tall-VS-Normal |
1.352220E-02 |
| Follicular-VS-Other |
3.247400E-01 |
| Follicular-VS-Normal |
9.992800E-04 |
| Other-VS-Normal |
8.536400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.362800E-01 |
| Normal-vs-N1 |
1.397660E-03 |
| N0-vs-N1 |
9.167800E-04 |
|
|
